Brensocatib—another therapeutic “window of opportunity” for patients with bronchiectasis
10.3390/jcm15031257 · doi-reference
Should antibiotic prophylaxis be routinely used in patients with antibody-mediated primary immunodeficiency?
10.1016/j.jaip.2017.11.024 · doi-reference
Use of intravenous immunoglobulin and adjunctive therapies in the treatment of primary immunodeficiencies
10.1016/j.clim.2009.10.003 · doi-reference
Antimicrobial prophylaxis for primary immunodeficiencies
10.1097/aci.0b013e328332be33 · doi-reference
Update on the use of immunoglobulin in human disease: a review of evidence
10.1016/j.jaci.2016.09.023 · doi-reference
Efficacy and safety of DPP-1 inhibitors in bronchiectasis: a GRADE-assessed meta-analysis of randomized controlled trials
10.1186/s12931-025-03407-2 · doi-reference
Long-term macrolide maintenance therapy in non-CF bronchiectasis: evidence and questions
10.1016/j.rmed.2014.09.005 · doi-reference
Double-blind, placebo-controlled, randomized trial on low-dose azithromycin prophylaxis in patients with primary antibody deficiencies
10.1016/j.jaci.2019.01.051 · doi-reference
Impact of trough IgG on pneumonia incidence in primary immunodeficiency: a meta-analysis of clinical studies
10.1016/j.clim.2010.06.012 · doi-reference
Immunomodulatory and anti-inflammatory properties of immunoglobulin G antibodies
10.1111/imr.13404 · doi-reference
Intracellular pathogens: host immunity and microbial persistence strategies
10.1155/2019/1356540 · doi-reference
Lung disease in primary antibody deficiencies
10.1016/j.jaip.2016.08.005 · doi-reference
Pulmonary complications of common variable immunodeficiency
10.1016/s1081-1206(10)60853-8 · doi-reference
Current concepts: common variable immunodeficiency
10.1016/j.anai.2025.11.009 · doi-reference
2025 Inborn errors of immunity practice parameter
10.1016/j.anai.2025.10.026 · doi-reference
State-of-the-art diagnostic evaluation of common variable immunodeficiency
10.1016/j.anai.2021.03.005 · doi-reference
Serial lung function tests in primary immune deficiency
10.1111/j.1365-2249.2007.03550.x · doi-reference
Screening for primary immune deficiency among patients with bronchiectasis
10.1016/j.revmed.2024.06.010 · doi-reference
Secondary immunodeficiency and noncystic fibrosis bronchiectasis
10.4046/trd.2024.0015 · doi-reference
Primary humoral immunodeficiencies and bronchiectasis in adults
10.3390/jcm15010179 · doi-reference
Diagnosis and management of bronchiectasis
10.1503/cmaj.160830 · doi-reference
Criteria and definitions for the radiological and clinical diagnosis of bronchiectasis in adults for use in clinical trials: international consensus recommendations
10.1016/s2213-2600(21)00277-0 · doi-reference
The treatment of primary immune deficiencies: lessons learned and future opportunities
10.1007/s12016-022-08950-0 · doi-reference
Diagnostic testing for interstitial lung disease in common variable immunodeficiency: a systematic review
10.3389/fimmu.2023.1190235 · doi-reference
Chronic lung disease in primary antibody deficiency
10.1016/j.iac.2020.03.003 · doi-reference
